TY - JOUR
T1 - Predictors of mean arterial pressure morning rate of rise and power function in subjects undergoing ambulatory blood pressure recording
AU - Head, Geoff Albert
AU - Andrianopoulos, Nick
AU - McGrath, Barry Patrick
AU - Martin, Catherine Ann
AU - Carrington, Melinda
AU - Lukoshkova, Elena V
AU - Davern, Pamela J
AU - Jennings, Garry L R
AU - Reid, Christopher Michael
PY - 2014
Y1 - 2014
N2 - Background: We determined clinical predictors of the rate of rise (RoR) in blood pressure in the morning as well as a novel
measure of the power of the BP surge (BPpower) derived from ambulatory blood pressure recordings.
Methods: BPpower and RoR were calculated from 409 ambulatory blood pressure (ABP) recordings from subjects attending a
cardiovascular risk clinic. Anthropometric data, blood biochemistry, and history were recorded. The 409 subjects were 20?82
years old (average 57, SD = 13), 46 male, 9 with hypertension but not on medication and 34 on antihypertensive
medication.
Results: Average RoR was 11.1 mmHg/hour (SD = 8) and BPpower was 273 mmHg2
/hour (SD = 235). Only cholesterol, low
density lipoprotein and body mass index (BMI) were associated with higher BPpower and RoR (P,0.05) from 25 variables
assessed. BPpower was lower in those taking beta-blockers or diuretics. Multivariate analysis identified that only BMI was
associated with RoR (4.2 increase/unit BMI, P = 0.020) while cholesterol was the only remaining associated variable with
BPpower (17.5 increase/mmol/L cholesterol, P = 0.047). A follow up of 213 subjects with repeated ABP after an average 1.8
years identified that baseline cholesterol was the only predictor for an increasing RoR and BPpower (P,0.05). 37 patients who
commenced statin subsequently had lower BPpower whereas 90 age and weight matched controls had similar BPpower on
follow-up.
Conclusions: Cholesterol is an independent predictor of a greater and more rapid rise in morning BP as well as of further
increases over several years. Reduction of cholesterol with statin therapy is very effective in reducing the morning blood
pressure surge.
AB - Background: We determined clinical predictors of the rate of rise (RoR) in blood pressure in the morning as well as a novel
measure of the power of the BP surge (BPpower) derived from ambulatory blood pressure recordings.
Methods: BPpower and RoR were calculated from 409 ambulatory blood pressure (ABP) recordings from subjects attending a
cardiovascular risk clinic. Anthropometric data, blood biochemistry, and history were recorded. The 409 subjects were 20?82
years old (average 57, SD = 13), 46 male, 9 with hypertension but not on medication and 34 on antihypertensive
medication.
Results: Average RoR was 11.1 mmHg/hour (SD = 8) and BPpower was 273 mmHg2
/hour (SD = 235). Only cholesterol, low
density lipoprotein and body mass index (BMI) were associated with higher BPpower and RoR (P,0.05) from 25 variables
assessed. BPpower was lower in those taking beta-blockers or diuretics. Multivariate analysis identified that only BMI was
associated with RoR (4.2 increase/unit BMI, P = 0.020) while cholesterol was the only remaining associated variable with
BPpower (17.5 increase/mmol/L cholesterol, P = 0.047). A follow up of 213 subjects with repeated ABP after an average 1.8
years identified that baseline cholesterol was the only predictor for an increasing RoR and BPpower (P,0.05). 37 patients who
commenced statin subsequently had lower BPpower whereas 90 age and weight matched controls had similar BPpower on
follow-up.
Conclusions: Cholesterol is an independent predictor of a greater and more rapid rise in morning BP as well as of further
increases over several years. Reduction of cholesterol with statin therapy is very effective in reducing the morning blood
pressure surge.
UR - http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3965554/pdf/pone.0093186.pdf
U2 - 10.1371/journal.pone.0093186
DO - 10.1371/journal.pone.0093186
M3 - Article
SN - 1932-6203
VL - 9
JO - PLoS ONE
JF - PLoS ONE
IS - 3
M1 - e93186
ER -